APIActive Pharmaceutical Ingredients

Contate-Nos

Contact Us

Vamos conectar

Tem uma dúvida sobre nossos produtos? Devemos reverter o mais cedo possível

Eu concordo e aceito a Política de Privacidade e os Termos de Uso deste site.

Envie-nos um email: api@drreddys.com | +91 40 49002253

Eventos

01 Mar

Conheça nossa equipe em

CPhI Japan Connect

Agendar reunião

12 Jul

Conheça nossa equipe em

DCAT Week

Agendar reunião

10 Ago

Conheça nossa equipe em

CPhI North America

Agendar reunião

11 Out

Conheça nossa equipe em

CPhI Korea

Agendar reunião

09 Nov

Conheça nossa equipe em

CPhI Worldwide

Agendar reunião

16 Dez

Conheça nossa equipe em

CPhI China

Agendar reunião

Centro de Recursos

Dr. Reddy’s Fosaprepitant API offerings

Dr. Reddy’s Fosaprepitant API offerings

Apixaban API – ready-to-compress granules and finished dosage forms

Apixaban API – ready-to-compress granules and finished dosage forms

Apalutamide API – an attractive NCE-1 opportunity for generic pharma companies

Apalutamide API – an attractive NCE-1 opportunity for generic pharma companies

EMA Nitrosamine Guidance – Deadline March 31, 2021

EMA Nitrosamine Guidance – Deadline March 31, 2021

Colloidal Iron Complex Formulations – Understanding and Developing the Process

Colloidal Iron Complex Formulations – Understanding and Developing the Process

Rivaroxaban from Dr.Reddy’s: Full basket offerings of API and Finished formulations

Rivaroxaban from Dr.Reddy’s: Full basket offerings of API and Finished formulations

Best Supply Chain Team of the Year - Pharma- 2021

Best Supply Chain Team of the Year - Pharma- 2021

Dr. Reddy's Mirabegron API offering in both alpha and amorphous form

Dr. Reddy's Mirabegron API offering in both alpha and amorphous form

Palbociclib – how a novel process development approach provides IP advantages

Palbociclib – how a novel process development approach provides IP advantages

Patient centricity and supply chain security in 2021 - Rajesh Sadanandan speaks on CPhI Pharma Trends 2021

Patient centricity and supply chain security in 2021 - Rajesh Sadanandan speaks on CPhI Pharma Trends 2021